U.A.E CE-Ventures backs UK's Oyster Therapeutics in $60 million Series A round UK-based biotech company Oyster Therapeutics has raised $60 million in Series A funding, with participation from CE-Ventures, the... News • 11 November, 2026 Oyster Therapeutics CE-Ventures